IVDT_In Vitro Diagnostics Technology

IVD Technology, November/December 2012

Issue link: http://dc.cn.ubm-us.com/i/92152

Contents of this Issue

Navigation

Page 43 of 43

"Through strategic growth of our portfolio we can now offer a complete service." Fiona Marshall Managing Director BBInternational At BBI we believe in sharing our knowledge and expertise to help you achieve and succeed in your goals. And with 25 years in the industry, we're sure that our team of experts can help you overcome many of the challenges you may be facing. Whether it is contract manufacturing or the development of new assay platforms, BBI can work with you to bring new or existing products to life. Through the incorporation of BBI Enzymes in 2007 and the acquisition of SCIPAC in 2010, the Group can now assist in all stages of your IVD assay development journey, supplying enzymes, antibodies and antigens, nanoparticle labels and patient samples. Join us at Medica, Hall 1 Stand F24 and let us take you on a journey. To pre-arrange an appointment with a member of our team call us on +44 (0) 29 2060 9223 or email meetatmedica@bbigold.com. www.bbigold.com/journey #BBIMedica2012

Articles in this issue

Links on this page

Archives of this issue

view archives of IVDT_In Vitro Diagnostics Technology - IVD Technology, November/December 2012